ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
+9.51%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$28.5B
AUM Growth
+$2.42B
(+9.3%)
Cap. Flow
+$550M
Cap. Flow
% of AUM
1.93%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
1,921
New
171
Increased
1,320
Reduced
356
Closed
71
Top Buys
| 1 |
Microsoft
MSFT
|
$111M |
| 2 |
VF Corp
VFC
|
$69M |
| 3 |
Amazon
AMZN
|
$60.3M |
| 4 |
Stanley Black & Decker
SWK
|
$58M |
| 5 |
West Pharmaceutical
WST
|
$42.9M |
Top Sells
| 1 |
Target
TGT
|
$158M |
| 2 |
Apple
AAPL
|
$118M |
| 3 |
Cardinal Health
CAH
|
$44.3M |
| 4 |
Fortinet
FTNT
|
$39.6M |
| 5 |
Exxon Mobil
XOM
|
$33.1M |
Sector Composition
| 1 | Technology | 21.73% |
| 2 | Industrials | 12.19% |
| 3 | Consumer Staples | 11.65% |
| 4 | Healthcare | 11.12% |
| 5 | Financials | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Janus International
JBI
$1.44B
| $100K | ﹤0.01% |
+10,510
| New | +$100K |
|
1652
Vanda Pharmaceuticals
VNDA
$272M
| $99.3K | ﹤0.01% |
13,432
+1,014
| +8% | +$7.49K |
|
1653
Sweetgreen
SG
$1.06B
| $97.9K | ﹤0.01% |
+11,418
| New | +$97.9K |
|
1654
Esperion Therapeutics
ESPR
$540M
| $97.1K | ﹤0.01% |
15,583
+2,643
| +20% | +$16.5K |
|
|
NKLA
1655
DELISTED
Nikola Corporation Common Stock
NKLA
| $96.8K | ﹤0.01% |
1,494
+362
| +32% | +$23.5K |
|
1656
Sangamo Therapeutics
SGMO
$165M
| $96.6K | ﹤0.01% |
30,772
+3,511
| +13% | +$11K |
|
1657
Tango Therapeutics
TNGX
$772M
| $96.4K | ﹤0.01% |
+13,293
| New | +$96.4K |
|
1658
Yext
YEXT
$1.1B
| $95.7K | ﹤0.01% |
14,653
+2,099
| +17% | +$13.7K |
|
1659
LegalZoom.com
LZ
$1.86B
| $95.5K | ﹤0.01% |
12,344
+1,769
| +17% | +$13.7K |
|
|
CHS
1660
DELISTED
Chicos FAS, Inc.
CHS
| $95.5K | ﹤0.01% |
19,404
+2,496
| +15% | +$12.3K |
|
1661
iHeartMedia
IHRT
$315M
| $95.1K | ﹤0.01% |
15,513
+2,224
| +17% | +$13.6K |
|
1662
CureVac
CVAC
$1.21B
| $94.9K | ﹤0.01% |
15,738
-32
| -0.2% | -$193 |
|
1663
Sutro Biopharma
STRO
$89.9M
| $94.5K | ﹤0.01% |
+11,690
| New | +$94.5K |
|
|
AGEN
1664
Agenus
AGEN
$138M
| $94.1K | ﹤0.01% |
1,997
+408
| +26% | +$19.2K |
|
1665
ARKO Corp
ARKO
$559M
| $93K | ﹤0.01% |
+10,735
| New | +$93K |
|
1666
PureCycle Technologies
PCT
$2.41B
| $92.4K | ﹤0.01% |
13,673
+1,959
| +17% | +$13.2K |
|
1667
Open Lending Corp
LPRO
$267M
| $91.6K | ﹤0.01% |
13,575
+1,946
| +17% | +$13.1K |
|
1668
Repay Holdings
RPAY
$506M
| $90.8K | ﹤0.01% |
+11,274
| New | +$90.8K |
|
1669
Edgewise Therapeutics
EWTX
$1.64B
| $90.3K | ﹤0.01% |
+10,105
| New | +$90.3K |
|
1670
SIGA Technologies
SIGA
$603M
| $89.1K | ﹤0.01% |
12,100
+758
| +7% | +$5.58K |
|
|
PAYA
1671
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $88.6K | ﹤0.01% |
+11,260
| New | +$88.6K |
|
1672
Conduent
CNDT
$447M
| $88.5K | ﹤0.01% |
21,846
+3,131
| +17% | +$12.7K |
|
1673
Kezar Life Sciences
KZR
$29.8M
| $87.5K | ﹤0.01% |
1,243
+88
| +8% | +$6.19K |
|
|
SAFE
1674
Safehold
SAFE
$1.17B
| $87.4K | ﹤0.01% |
+1,832
| New | +$87.4K |
|
1675
Planet Labs
PL
$1.98B
| $87K | ﹤0.01% |
20,008
+2,867
| +17% | +$12.5K |
|